Turkey Again Slashes Drug Prices; Manufacturers And Pharmacists Cry Foul
This article was originally published in The Pink Sheet Daily
Executive Summary
The most recent policies place Turkey in a position where drugs will be sold for 30% to 50% less than the lowest European price, according to the Turkish Association of Research-Based Pharmaceutical Companies.
You may also be interested in...
Nycomed Expands In Turkey, Despite Tough Pharma Environment
Nycomed has gained the rights to market over 10 pharmaceutical products in Turkey, consolidating its position in the country and keeping to its strategy of growth in pharmerging markets.
Nycomed Expands In Turkey, Despite Tough Pharma Environment
Nycomed has gained the rights to market over 10 pharmaceutical products in Turkey, consolidating its position in the country and keeping to its strategy of growth in pharmerging markets.
Abbott, Eli Lilly, Novartis: Emerging Markets Earnings Round Up (Part 1)
Year-end and Q4 pharma earnings results emphasized emerging markets as one positive in a challenging environment posed by U.S. healthcare reform and European price cuts and austerity measures. Pharma companies stressed cost-cutting actions such as restructuring their businesses and closing facilities in the U.S. and Europe, while simultaneously discussing increased resource allocation for Asia and other emerging markets.